Triamcinolone - Generic Drug Details
✉ Email this page to a colleague
What are the generic drug sources for triamcinolone and what is the scope of freedom to operate?
Triamcinolone
is the generic ingredient in thirty-one branded drugs marketed by Astellas, Delcor Asset Corp, Barr, Impax Labs, Ivax Sub Teva Pharms, Mylan, Purepac Pharm, Roxane, Sandoz, Teva, Watson Labs, Abbvie, Chattem Sanofi, Ivax Pharms, Solvay, Actavis Mid Atlantic, Alkem Labs Ltd, Alpharma Us Pharms, Ambix, Chartwell Rx, Cosette, Encube, Fougera Pharms, Glenmark Pharms Ltd, Macleods Pharms Ltd, Micro Labs, Morton Grove, Padagis Us, Pharmaderm, Pharmafair, Strides Pharma, Taro, Topiderm, Crown Labs, Savage Labs, Pacira Pharms Inc, Apothecon, Amneal, Eugia Pharma, Long Grove Pharms, Mylan Labs Ltd, Parnell, Teva Pharms Usa, Allergan, Harrow Eye, Epic Pharma Llc, Pai Holdings Pharm, Quagen, Wockhardt Bio Ag, Aurobindo Pharma Ltd, Cintex Svcs, Glenmark Pharms, Padagis Israel, Cmp Pharma Inc, Akorn, Lyne, Lupin Atlantis, Sanofi Aventis Us, Apotex, Perrigo Pharma Intl, Sun Pharm Inds Inc, Rising, Bausch And Lomb Inc, and Fosun Pharma, and is included in one hundred and sixty-seven NDAs. There are seven patents protecting this compound. Additional information is available in the individual branded drug profile pages.There are fifty-one drug master file entries for triamcinolone.
Summary for triamcinolone
US Patents: | 7 |
Tradenames: | 31 |
Applicants: | 64 |
NDAs: | 167 |
Drug Master File Entries: | 51 |
Raw Ingredient (Bulk) Api Vendors: | 76 |
Clinical Trials: | 397 |
Patent Applications: | 6,787 |
Formulation / Manufacturing: | see details |
Drug Prices: | Drug price trends for triamcinolone |
Drug Sales Revenues: | Drug sales revenues for triamcinolone |
DailyMed Link: | triamcinolone at DailyMed |
Recent Clinical Trials for triamcinolone
Identify potential brand extensions & 505(b)(2) entrants
Sponsor | Phase |
---|---|
Centre hospitalier de l'Université de Montréal (CHUM) | N/A |
Gadjah Mada University | Phase 1/Phase 2 |
Innovaderm Research Inc. | Phase 4 |
Medical Subject Heading (MeSH) Categories for triamcinolone
US Patents and Regulatory Information for triamcinolone
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Barr | TRIAMCINOLONE | triamcinolone | TABLET;ORAL | 084268-001 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Astellas | ARISTOCORT A | triamcinolone acetonide | CREAM;TOPICAL | 083017-004 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Mylan | TRIAMCINOLONE ACETONIDE | triamcinolone acetonide | OINTMENT;TOPICAL | 011600-001 | Approved Prior to Jan 1, 1982 | DISCN | Yes | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Apotex | TRIAMCINOLONE ACETONIDE | triamcinolone acetonide | SPRAY, METERED;NASAL | 214615-001 | Jan 19, 2023 | OTC | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
Purepac Pharm | TRIAMCINOLONE | triamcinolone | TABLET;ORAL | 084020-002 | Approved Prior to Jan 1, 1982 | DISCN | No | No | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |